Judith Michels

5PUBLICATIONS
58CO-AUTHORS
Molecular targetsMedical mycologyMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 08, 2025
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).

Michael K Wong, Mohammed M Milhem, Joseph J Sacco

|Sep 18, 2024
NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment.

Carlos de la Calle-Fabregat, Josep Calafell-Segura, Margaux Gardet

|Oct 27, 2023
APR-246 increases tumor antigenicity independent of p53.

Judith Michels, Divya Venkatesh, Cailian Liu

|Apr 17, 2023
Clinical Relevance of BRCA1 Promoter Methylation Testing in Patients with Ovarian Cancer.

Félix Blanc-Durand, Roseline Tang, Margaux Pommier

|Jan 19, 2023
Evaluating immune response <i>in vitro</i> in a relevant microenvironment: a high-throughput microfluidic model for clinical screening.

Flora Doffe, Layla Fuoco, Judith Michels

Pageof 1